The Syros will be slotted between the Sonet and the Seltos. Like the Inster EV, the new SUV is based on the K1 platform and ...
Shares of Senores Pharmaceuticals Limited made a healthy debut on the exchange to list at a 53.45% premium. The scrip listed Rs 593.70 per share on BSE, a premium of 51.84% and Rs 600 per share on NSE ...
The Ahmedabad-based pharmaceutical firm's shares listed at Rs 600 on the National Stock Exchange, a premium of 53.45%.
Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock ...
Senores Pharmaceuticals Ltd witnessed a stellar debut on stock exchanges, with shares surging nearly 43% against the issue ...
Senores Pharmaceuticals Ltd had a successful IPO, with shares surging over 53% from the issue price of Rs 391. The company's market valuation hit Rs 2,657.29 crore. The proceeds will aid in expanding ...
India Today on MSN5d
Senores Pharmaceuticals shares list at 54% premium, bumper debut on D-StreetSenores Pharmaceuticals shares opened at Rs 600 on the National Stock Exchange at a premium of 53.45% over its IPO price of ...
According to market observers, the grey market is expecting that Senores Pharmaceuticals IPO listing price would be around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback